CTI BIOPHARMA CORP - FORM 10-K - EX-21.1 - EXHIBIT 21.1

file	filename
EX-32 - EXHIBIT 32 - CTI BIOPHARMA CORP	a2017exhibit32sect906certc.htm
EX-31.2 - EXHIBIT 31.2 - CTI BIOPHARMA CORP	a2017exhibit312sect302cert.htm
EX-31.1 - EXHIBIT 31.1 - CTI BIOPHARMA CORP	a2017exhibit311sect302cert.htm
EX-23.1 - EXHIBIT 23.1 - CTI BIOPHARMA CORP	a2017exhibit231accountingf.htm
EX-12.1 - EXHIBIT 12.1 - CTI BIOPHARMA CORP	a2017exhibit121ratioofearn.htm
EX-10.58 - EXHIBIT 10.58 - CTI BIOPHARMA CORP	waivertoloanandsecurityagr.htm
10-K - 10-K - CTI BIOPHARMA CORP	cti10k12312017document.htm

Exhibit 21.1

Subsidiaries of CTI BioPharma Corp.

Aequus Biopharma, Inc., a Washington corporation and CTI Life Sciences Ltd., a U.K. limited company.

The above paragraph includes all material subsidiaries of CTI BioPharma Corp.

CTI BIOPHARMA CORP - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 7, 2018